Biofrontera
BFRIW
6 hedge funds and large institutions have $7.27K invested in Biofrontera in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
12.55% less ownership
Funds ownership: 16.56% → 4.01% (-13%)
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
52% less capital invested
Capital invested by funds: $15K → $7.27K (-$7.73K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$49 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.15K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$204 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$133 |
BFRIW Hedge Fund Activity: Q2 2024 in Review
6 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q2 2024, worth a combined $7.27K — down 52% from $15K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BFRIW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, adding an estimated $49. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.15K sold.
- 6 institutional investors held Biofrontera (BFRIW) as of Q2 2024, down from 7 in Q1 2024.
- Funds reported $7.27K of Biofrontera stock for Q2 2024, down 52% quarter-over-quarter.
- 0 funds opened new Biofrontera positions in Q2 2024 and 1 closed out, a net change of -1 holder.
- The largest Biofrontera buyer in Q2 2024 was Citadel Advisors, an estimated $49 added.
- The largest Biofrontera seller in Q2 2024 was Susquehanna International Group, an estimated $1.15K sold.
Based on aggregated 13F filings for Q2 2024.